Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice

Barbara A. Wasowska, Zhiping Qian, David L. Cangello, Edward Behrens, Khanh Van Tran, Jodi Layton, Fred Sanfilippo, William M. Baldwin

Research output: Contribution to journalArticle

Abstract

Background. Alloantibody is an intrinsic component of the immune response to organ transplants. Although alloantibodies have been correlated with decreased graft survival, the mechanisms of alloantibody-mediated injury remain largely undefined in vivo. In the present study, we have established a model of alloantibody-mediated graft injury using B10.A (H-2a) hearts transplanted to wild type (WT) or immunoglobulin knock out (IgKO) C57BL-Igh-6 (H-2b) mice. Methods. Alloantibodies were measured in the circulation and graft by flow cytometry and in immunofluorescence staining, respectively. Intragraft cytokine mRNA expression was evaluated using a competitive template reverse transcriptase polymerase chain reaction (RT-PCR) technique. P-selectin and von Willebrand factor expression were localized by immunoperoxidase staining. The capacity of alloantibodies to restore acute cardiac allograft rejection was tested by passive transfer of monoclonal antibodies (mAbs) against donor major histocompatibility complex (MHC) class I antigens to IgKO recipients. Results. B10.A cardiac allografts are rejected acutely by WT C57BL/6 recipients, but over 50% of the cardiac allografts survived more than 50 days after transplantation in IgKO mice. Competitive template RT-PCR on the cardiac transplants demonstrated similar levels of IL-1-α, IL-12 (p40), TNF-α, IL-2, IFN-γ, IL-4, and IL-10 mRNA in WT and IgKO recipients 8-10 days after transplantation, indicating that macrophage- and T-cell-dependent immune responses were intact in IgKO recipients. The rejection of B10.A hearts in WT recipients was characterized by interstitial and perivascular cellular infiltration; IgG, IgM, and complement (C3) deposition; vascular cell injury and intravascular platelet aggregation; and release of von Willebrand factor and P-selectin. In IgKO recipients the lower degree of vascular injury in the absence of alloantibody responses was reflected by the lack of release of von Willebrand factor and P-selectin, which remained confined to cytoplasmic storage granules of endothelial cells and platelets. Acute rejection of cardiac allografts was restored to IgKO recipients by passive transfer of proinflammatory IgG2b mAbs against donor MHC; recipients injected with isotype-matched control mAbs did not reject. In contrast, passive transfer of IgG1 mAbs against donor MHC failed to restore acute rejection of cardiac allografts to IgKO recipients. Passive transfer of IgG2b, but not IgG1 mAbs was associated with endothelial cell activation and platelet aggregation together with the release of preformed von Willebrand factor and P-selectin from storage granules. Conclusions. Acute rejection of cardiac allografts can be reconstituted in IgKO recipients by passive transfer of IgG2b, but not IgG1 antibody. This model allows the mechanism of alloantibody-mediate graft injury to be dissected in vivo.

Original languageEnglish (US)
Pages (from-to)727-736
Number of pages10
JournalTransplantation
Volume71
Issue number6
StatePublished - Mar 27 2001

Fingerprint

Isoantibodies
Knockout Mice
Immunoglobulins
Allografts
P-Selectin
von Willebrand Factor
Monoclonal Antibodies
Transplants
Immunoglobulin G
Major Histocompatibility Complex
Vascular System Injuries
Reverse Transcriptase Polymerase Chain Reaction
Platelet Aggregation
Wounds and Injuries
Endothelial Cells
Transplantation
Staining and Labeling
Cytoplasmic Granules
Cell Aggregation
Messenger RNA

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Wasowska, B. A., Qian, Z., Cangello, D. L., Behrens, E., Van Tran, K., Layton, J., ... Baldwin, W. M. (2001). Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation, 71(6), 727-736.

Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. / Wasowska, Barbara A.; Qian, Zhiping; Cangello, David L.; Behrens, Edward; Van Tran, Khanh; Layton, Jodi; Sanfilippo, Fred; Baldwin, William M.

In: Transplantation, Vol. 71, No. 6, 27.03.2001, p. 727-736.

Research output: Contribution to journalArticle

Wasowska, BA, Qian, Z, Cangello, DL, Behrens, E, Van Tran, K, Layton, J, Sanfilippo, F & Baldwin, WM 2001, 'Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice', Transplantation, vol. 71, no. 6, pp. 727-736.
Wasowska BA, Qian Z, Cangello DL, Behrens E, Van Tran K, Layton J et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation. 2001 Mar 27;71(6):727-736.
Wasowska, Barbara A. ; Qian, Zhiping ; Cangello, David L. ; Behrens, Edward ; Van Tran, Khanh ; Layton, Jodi ; Sanfilippo, Fred ; Baldwin, William M. / Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. In: Transplantation. 2001 ; Vol. 71, No. 6. pp. 727-736.
@article{6ea16debdfd34780906844c9f31d0abc,
title = "Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice",
abstract = "Background. Alloantibody is an intrinsic component of the immune response to organ transplants. Although alloantibodies have been correlated with decreased graft survival, the mechanisms of alloantibody-mediated injury remain largely undefined in vivo. In the present study, we have established a model of alloantibody-mediated graft injury using B10.A (H-2a) hearts transplanted to wild type (WT) or immunoglobulin knock out (IgKO) C57BL-Igh-6 (H-2b) mice. Methods. Alloantibodies were measured in the circulation and graft by flow cytometry and in immunofluorescence staining, respectively. Intragraft cytokine mRNA expression was evaluated using a competitive template reverse transcriptase polymerase chain reaction (RT-PCR) technique. P-selectin and von Willebrand factor expression were localized by immunoperoxidase staining. The capacity of alloantibodies to restore acute cardiac allograft rejection was tested by passive transfer of monoclonal antibodies (mAbs) against donor major histocompatibility complex (MHC) class I antigens to IgKO recipients. Results. B10.A cardiac allografts are rejected acutely by WT C57BL/6 recipients, but over 50{\%} of the cardiac allografts survived more than 50 days after transplantation in IgKO mice. Competitive template RT-PCR on the cardiac transplants demonstrated similar levels of IL-1-α, IL-12 (p40), TNF-α, IL-2, IFN-γ, IL-4, and IL-10 mRNA in WT and IgKO recipients 8-10 days after transplantation, indicating that macrophage- and T-cell-dependent immune responses were intact in IgKO recipients. The rejection of B10.A hearts in WT recipients was characterized by interstitial and perivascular cellular infiltration; IgG, IgM, and complement (C3) deposition; vascular cell injury and intravascular platelet aggregation; and release of von Willebrand factor and P-selectin. In IgKO recipients the lower degree of vascular injury in the absence of alloantibody responses was reflected by the lack of release of von Willebrand factor and P-selectin, which remained confined to cytoplasmic storage granules of endothelial cells and platelets. Acute rejection of cardiac allografts was restored to IgKO recipients by passive transfer of proinflammatory IgG2b mAbs against donor MHC; recipients injected with isotype-matched control mAbs did not reject. In contrast, passive transfer of IgG1 mAbs against donor MHC failed to restore acute rejection of cardiac allografts to IgKO recipients. Passive transfer of IgG2b, but not IgG1 mAbs was associated with endothelial cell activation and platelet aggregation together with the release of preformed von Willebrand factor and P-selectin from storage granules. Conclusions. Acute rejection of cardiac allografts can be reconstituted in IgKO recipients by passive transfer of IgG2b, but not IgG1 antibody. This model allows the mechanism of alloantibody-mediate graft injury to be dissected in vivo.",
author = "Wasowska, {Barbara A.} and Zhiping Qian and Cangello, {David L.} and Edward Behrens and {Van Tran}, Khanh and Jodi Layton and Fred Sanfilippo and Baldwin, {William M.}",
year = "2001",
month = "3",
day = "27",
language = "English (US)",
volume = "71",
pages = "727--736",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice

AU - Wasowska, Barbara A.

AU - Qian, Zhiping

AU - Cangello, David L.

AU - Behrens, Edward

AU - Van Tran, Khanh

AU - Layton, Jodi

AU - Sanfilippo, Fred

AU - Baldwin, William M.

PY - 2001/3/27

Y1 - 2001/3/27

N2 - Background. Alloantibody is an intrinsic component of the immune response to organ transplants. Although alloantibodies have been correlated with decreased graft survival, the mechanisms of alloantibody-mediated injury remain largely undefined in vivo. In the present study, we have established a model of alloantibody-mediated graft injury using B10.A (H-2a) hearts transplanted to wild type (WT) or immunoglobulin knock out (IgKO) C57BL-Igh-6 (H-2b) mice. Methods. Alloantibodies were measured in the circulation and graft by flow cytometry and in immunofluorescence staining, respectively. Intragraft cytokine mRNA expression was evaluated using a competitive template reverse transcriptase polymerase chain reaction (RT-PCR) technique. P-selectin and von Willebrand factor expression were localized by immunoperoxidase staining. The capacity of alloantibodies to restore acute cardiac allograft rejection was tested by passive transfer of monoclonal antibodies (mAbs) against donor major histocompatibility complex (MHC) class I antigens to IgKO recipients. Results. B10.A cardiac allografts are rejected acutely by WT C57BL/6 recipients, but over 50% of the cardiac allografts survived more than 50 days after transplantation in IgKO mice. Competitive template RT-PCR on the cardiac transplants demonstrated similar levels of IL-1-α, IL-12 (p40), TNF-α, IL-2, IFN-γ, IL-4, and IL-10 mRNA in WT and IgKO recipients 8-10 days after transplantation, indicating that macrophage- and T-cell-dependent immune responses were intact in IgKO recipients. The rejection of B10.A hearts in WT recipients was characterized by interstitial and perivascular cellular infiltration; IgG, IgM, and complement (C3) deposition; vascular cell injury and intravascular platelet aggregation; and release of von Willebrand factor and P-selectin. In IgKO recipients the lower degree of vascular injury in the absence of alloantibody responses was reflected by the lack of release of von Willebrand factor and P-selectin, which remained confined to cytoplasmic storage granules of endothelial cells and platelets. Acute rejection of cardiac allografts was restored to IgKO recipients by passive transfer of proinflammatory IgG2b mAbs against donor MHC; recipients injected with isotype-matched control mAbs did not reject. In contrast, passive transfer of IgG1 mAbs against donor MHC failed to restore acute rejection of cardiac allografts to IgKO recipients. Passive transfer of IgG2b, but not IgG1 mAbs was associated with endothelial cell activation and platelet aggregation together with the release of preformed von Willebrand factor and P-selectin from storage granules. Conclusions. Acute rejection of cardiac allografts can be reconstituted in IgKO recipients by passive transfer of IgG2b, but not IgG1 antibody. This model allows the mechanism of alloantibody-mediate graft injury to be dissected in vivo.

AB - Background. Alloantibody is an intrinsic component of the immune response to organ transplants. Although alloantibodies have been correlated with decreased graft survival, the mechanisms of alloantibody-mediated injury remain largely undefined in vivo. In the present study, we have established a model of alloantibody-mediated graft injury using B10.A (H-2a) hearts transplanted to wild type (WT) or immunoglobulin knock out (IgKO) C57BL-Igh-6 (H-2b) mice. Methods. Alloantibodies were measured in the circulation and graft by flow cytometry and in immunofluorescence staining, respectively. Intragraft cytokine mRNA expression was evaluated using a competitive template reverse transcriptase polymerase chain reaction (RT-PCR) technique. P-selectin and von Willebrand factor expression were localized by immunoperoxidase staining. The capacity of alloantibodies to restore acute cardiac allograft rejection was tested by passive transfer of monoclonal antibodies (mAbs) against donor major histocompatibility complex (MHC) class I antigens to IgKO recipients. Results. B10.A cardiac allografts are rejected acutely by WT C57BL/6 recipients, but over 50% of the cardiac allografts survived more than 50 days after transplantation in IgKO mice. Competitive template RT-PCR on the cardiac transplants demonstrated similar levels of IL-1-α, IL-12 (p40), TNF-α, IL-2, IFN-γ, IL-4, and IL-10 mRNA in WT and IgKO recipients 8-10 days after transplantation, indicating that macrophage- and T-cell-dependent immune responses were intact in IgKO recipients. The rejection of B10.A hearts in WT recipients was characterized by interstitial and perivascular cellular infiltration; IgG, IgM, and complement (C3) deposition; vascular cell injury and intravascular platelet aggregation; and release of von Willebrand factor and P-selectin. In IgKO recipients the lower degree of vascular injury in the absence of alloantibody responses was reflected by the lack of release of von Willebrand factor and P-selectin, which remained confined to cytoplasmic storage granules of endothelial cells and platelets. Acute rejection of cardiac allografts was restored to IgKO recipients by passive transfer of proinflammatory IgG2b mAbs against donor MHC; recipients injected with isotype-matched control mAbs did not reject. In contrast, passive transfer of IgG1 mAbs against donor MHC failed to restore acute rejection of cardiac allografts to IgKO recipients. Passive transfer of IgG2b, but not IgG1 mAbs was associated with endothelial cell activation and platelet aggregation together with the release of preformed von Willebrand factor and P-selectin from storage granules. Conclusions. Acute rejection of cardiac allografts can be reconstituted in IgKO recipients by passive transfer of IgG2b, but not IgG1 antibody. This model allows the mechanism of alloantibody-mediate graft injury to be dissected in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0035957197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957197&partnerID=8YFLogxK

M3 - Article

C2 - 11330533

AN - SCOPUS:0035957197

VL - 71

SP - 727

EP - 736

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -